Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 9;9(7):868.
doi: 10.3390/healthcare9070868.

Use of Immunochromatographic SARS-CoV-2 Antigen Testing in Eight Long-Term Care Facilities for the Elderly

Martina Ifko  1 , Miha Skvarc  2   3
Affiliations

Use of Immunochromatographic SARS-CoV-2 Antigen Testing in Eight Long-Term Care Facilities for the Elderly

Martina Ifko et al. Healthcare (Basel). .

Abstract

The clinical validation of the NADAL COVID-19 antigen test (Nal von Minden, Moers, Germany) started in eight Slovenian long-term health care facilities in October 2020. The purpose of clinical validation is to implement the test into the everyday working process in long-term care (LTC) facilities and demonstrate how it can be used to mitigate the spread of the virus in these environments. The facilities compared the results of antigen tests to the results obtained using Cobas 6800 SARS-CoV-2 real-time reverse transcription polymerase chain reaction (RT-PCR) (Roche, USA). Sensitivity (86.96%, 95% CI: 66.41-97.23%) and specificity (88.24%, 95% CI: 80.35-93.77%) of the NADAL COVID-19 antigen test were good. Rapid antigen testing served well for early detection of infection and helped to prevent and control spread of the SARS Cov2 in six out of eight LTCs. Moreover, mini-outbreaks were quickly resolved in all six LTCs. Locally validated immunochromatographic SARS-CoV-2 antigen testing can be used to contain the spread of the virus in LTCs. Antigen tests also deliver accurate information very quickly if used early with a low threshold. The NADAL COVID-19 antigen test proved to be a good screening tool to detect SARS-COV-2 in LTCs.

Keywords: POCT—point of care testing; clinical validation; immunochromatographic SARS-CoV-2 antigen test; long-term care.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. European Commission Commission Recommendation on COVID-19 Testing Strategies, Including the Use of Rapid Antigen Tests. [(accessed on 28 October 2020)]; Available online: https://ec.europa.eu/health/sites/health/files/preparedness_response/doc....
    1. ECDC Diagnostic Testing and Screening for SARS-CoV-2. [(accessed on 28 October 2020)]; Available online: https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing.
    1. ECDC Increase in Fatal Cases of COVID-19 among Long-Term Care Facility Residents in the EU/EEA and the UK. [(accessed on 7 December 2020)]; Available online: https://www.ecdc.europa.eu/sites/default/files/documents/Increase-fatal-....
    1. Covid-19 Tracker. [(accessed on 15 December 2020)]; Available online: https://covid-19.sledilnik.org/en/stats.
    1. World Health Organisation Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection Using Rapid Immunoassays. Interim Guidance. 11 September 2020. [(accessed on 28 October 2020)]; Available online: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnos....

LinkOut - more resources